Michael A. Caligiuri
, M.D., president of City of Hope National Medical Center, and Deana and Steve Campbell Physician-in-Chief Distinguished Chair, has been elected to the National Academy of Medicine (NAM), one of the highest honors in the fields of health and medicine. Membership in NAM recognizes individuals who have demonstrated outstanding professional achievements and commitment to service.
“City of Hope is pleased that Dr. Caligiuri has been elected to the National Academy of Medicine, a highly distinguished group of medical, health and public health leaders,” said City of Hope President and Chief Executive Officer Robert W. Stone
. “This honor is a testament to his dedication to patients and his contributions to cancer research and science.”
New members are elected by current members through a process that recognizes individuals who have made major contributions to the advancement of the medical sciences, health care and public health.
Caligiuri, well-known for his immunology research on human natural killer cells, is a world-renowned physician, scientist, builder, innovator, leader and visionary who is dedicated to developing the next generation of leading-edge cancer therapies, rapidly delivering them to patients and ultimately curing the disease.
He joined City of Hope in February 2018. Caligiuri is developing new paradigms for translating state-of-the-art research into practice at City of Hope, the community and beyond that will further move the institution to the leading edge of cancer treatment and care. He is also responsible for optimizing the patient care system to ensure the highest quality and safest patient experience.
Prior to joining City of Hope, Caligiuri worked as a physician, scientist and leader in the cancer program at The Ohio State University. He spent the past decade as chief executive officer of The James Cancer Hospital and Solove Research Institute and directed The Ohio State University Comprehensive Cancer Center for 14 years, recruiting over 300 cancer physicians and scientists.
Caligiuri is also the immediate past president of the American Association for Cancer Research, the world's largest cancer research organization with 40,000 members in 120 countries. In addition to serving as president of the AACR, he was also recently named a fellow of that organization.
As a physician-scientist, Caligiuri’s research focuses on the development and activation of human natural killer cells and their modulation for the treatment of leukemia, myeloma and glioblastoma. More than 1,000 cancer patients have been treated on clinical protocols that have emanated from the Caligiuri laboratory. He also has trained over 120 undergraduate, graduate or postgraduate students in his laboratory who have received over 200 university, state, national or international awards.
NAM, established in 1970 as the Institute of Medicine, is an independent organization of eminent professionals from diverse fields including health and medicine; the natural, social, and behavioral sciences; and beyond. It serves alongside the National Academy of Sciences and the National Academy of Engineering as an adviser to the nation and the international community. Through its domestic and global initiatives, NAM works to address critical issues in health, medicine and related policy and inspire positive action across sectors. NAM collaborates closely with its peer academies and other divisions within the National Academies of Sciences, Engineering and Medicine.